MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Catalyst Pharmaceuticals Historical Prices 2011-2026 | CPRX
Annual Historical Prices Catalyst Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.6 | 14.7 | 14.3 | 5.76 | 3.64 | 4.11 | 2.52 | 3.39 | 1.12 | 1.86 | 3.65 | 1.95 | 0.52 | 1.08 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.6 | 0.52 | 5.66 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M |  USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
8.01 | $ 18.33 | -0.92 % | $ 2.7 B | USA |
 |
Amgen
AMGN
|
292 | $ 343.48 | 0.47 % | $ 184 B | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
46.7 | $ 72.81 | 5.02 % | $ 9.74 B | USA |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Aytu BioScience
AYTU
|
2.51 | $ 2.72 | 4.62 % | $ 17.1 M | USA |
 |
Adagene
ADAG
|
1.56 | $ 2.99 | 8.55 % | $ 168 M | China |
 |
Biogen
BIIB
|
133 | $ 177.96 | -1.07 % | $ 25.9 B | USA |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.12 | -1.74 % | $ 7.51 B |  Australia |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M |  Canada |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
1.37 | $ 1.4 | -0.71 % | $ 262 M | USA |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
Ascendis Pharma A/S
ASND
|
153 | $ 223.74 | -1.05 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Burford Capital Limited
BUR
|
10.6 | $ 9.85 | 1.65 % | $ 1.59 B | Britain |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 4.13 | 2.92 % | $ 8.99 B |  Israel |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
BioNTech SE
BNTX
|
95.4 | $ 110.82 | -2.58 % | $ 27.2 B | Germany |
 |
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.39 | 1.09 % | $ 355 M | Britain |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |
 |
Cardiff Oncology
CRDF
|
4.08 | $ 1.72 | -2.0 % | $ 82 M | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M | Britain |
 |
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
5.91 | $ 14.17 | 3.55 % | $ 4.38 B | USA |
 |
Compugen Ltd.
CGEN
|
1.65 | $ 1.85 | 0.27 % | $ 166 M | Israel |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Atreca
BCEL
|
1.27 | - | -11.76 % | $ 5.79 M | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
8.31 | $ 6.68 | 1.52 % | $ 1.38 B | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Beam Therapeutics
BEAM
|
30.4 | $ 28.17 | 1.99 % | $ 2.32 B | USA |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |